OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
214,467,875
Total 13F shares
13,505,162
Share change
-2,078,730
Total reported value
$60,113,388
Put/Call ratio
130%
Price per share
$4.45
Number of holders
67
Value change
-$11,835,912
Number of buys
25
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2017

As of 31 Dec 2017, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,505,162 shares. The largest 10 holders included Versant Venture Management, LLC, JENNISON ASSOCIATES LLC, SV Health Investors, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, and MORGAN STANLEY. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.